Glucocorticoids, stress and obesity

Obesity and the associated metabolic syndrome have been suggested to be the consequence of a maladaptation to chronic stress exposure mediated by a dysregulation of neuroendocrine axes. The hypothalamic–pituitary–adrenal (HPA) axis represents the major hormone system responsible for maintenance of the homeostatic balance in response to stress. The brainstem nuclei and the limbic regions are strongly involved in stressor neural processing and represent a regulatory network for the HPA axis. Moreover, the same neuroendocrine stress centers are involved in the regulation of feeding behavior following acute and chronic stress exposure. Studies performed in experimental animals suggest that consumption of so-called comfort foods, while favoring an adaptation to the detrimental impact of chronic stress on the reward system, may, in turn, lead to the rapid development of obesity. Available data also indicate that the endocannabinoid system modulates the HPA axis and that its type 1 receptors, which are extensively localized in the hypothalamus and in limbic structures, are involved in the regulation of the stress response and the reward mechanisms. Based on extensive clinical experience and studies performed in experimental animals, we developed the concept that there is a specific phenotype of individuals who may become obese as a result of exposure to major stressful events.

[1]  Joseph E LeDoux The Emotional Brain, Fear, and the Amygdala , 2003, Cellular and Molecular Neurobiology.

[2]  D. Cota,et al.  The emerging role of the endocannabinoid system in endocrine regulation and energy balance. , 2006, Endocrine reviews.

[3]  X. Qiang,et al.  The obesity pandemic: where have we been and where are we going? , 2004, Obesity research.

[4]  H. V. van Praag,et al.  Can stress cause depression? , 2005, Progress in neuro-psychopharmacology & biological psychiatry.

[5]  M. Palkovits,et al.  Catecholaminergic systems in stress: structural and molecular genetic approaches. , 2009, Physiological reviews.

[6]  M. Dallman Fast glucocorticoid feedback favors ‘the munchies’ , 2003, Trends in Endocrinology & Metabolism.

[7]  L. Murphy,et al.  Function of Cannabinoid Receptors in the Neuroendocrine Regulation of Hormone Secretion , 1998, Neurobiology of Disease.

[8]  P. Björntorp,et al.  Neuroendocrine abnormalities in visceral obesity , 2000, International Journal of Obesity.

[9]  V. Viau,et al.  Functional Cross‐Talk Between the Hypothalamic‐Pituitary‐Gonadal and ‐Adrenal Axes , 2002, Journal of neuroendocrinology.

[10]  J Wardle,et al.  Stress and Food Choice: A Laboratory Study , 2000, Psychosomatic medicine.

[11]  M. Dallman,et al.  Chronic stress and comfort foods: self-medication and abdominal obesity , 2005, Brain, Behavior, and Immunity.

[12]  U. Pagotto,et al.  Stress‐related Development of Obesity and Cortisol in Women , 2009, Obesity.

[13]  R. Rosmond Role of stress in the pathogenesis of the metabolic syndrome , 2005, Psychoneuroendocrinology.

[14]  R. Hampson,et al.  Cannabinoid physiology and pharmacology: 30 years of progress , 2004, Neuropharmacology.

[15]  J W Rowe,et al.  Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[17]  James P. Herman,et al.  Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[18]  Jason U Tilan,et al.  Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome , 2007, Nature Medicine.

[19]  S. L. la Fleur,et al.  Interaction between corticosterone and insulin in obesity: regulation of lard intake and fat stores. , 2004, Endocrinology.

[20]  E. Ravussin,et al.  Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians , 2000, International Journal of Obesity.

[21]  Jens C. Pruessner,et al.  The brain and the stress axis: The neural correlates of cortisol regulation in response to stress , 2009, NeuroImage.

[22]  U. Pagotto,et al.  Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity , 2008, International Journal of Obesity.

[23]  Jens C. Pruessner,et al.  Deactivation of the Limbic System During Acute Psychosocial Stress: Evidence from Positron Emission Tomography and Functional Magnetic Resonance Imaging Studies , 2008, Biological Psychiatry.

[24]  C. Wotjak,et al.  Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. , 2008, Progress in brain research.

[25]  C. Sripada,et al.  The functional neuroanatomy of PTSD: a critical review. , 2008, Progress in brain research.

[26]  J. Manzanares,et al.  Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors , 2004, Neuropharmacology.

[27]  G. Chrousos,et al.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.

[28]  Jens C. Pruessner,et al.  Stress regulation in the central nervous system: evidence from structural and functional neuroimaging studies in human populations - 2008 Curt Richter Award Winner , 2010, Psychoneuroendocrinology.

[29]  S. L. la Fleur,et al.  Minireview: glucocorticoids--food intake, abdominal obesity, and wealthy nations in 2004. , 2004, Endocrinology.

[30]  P. Bernante,et al.  The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  S. Manuck,et al.  Ovarian dysfunction, stress, and disease: a primate continuum. , 2004, ILAR journal.

[32]  A. Levine,et al.  Why do we eat? A neural systems approach. , 1997, Annual review of nutrition.

[33]  W. Cullinan,et al.  Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. , 2004, Endocrinology.

[34]  R. Pasquali Obesity and androgens: facts and perspectives. , 2006, Fertility and sterility.

[35]  A. Bartolomucci,et al.  Stress and Depression: Preclinical Research and Clinical Implications , 2009, PloS one.

[36]  Robin Christensen,et al.  Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials , 2007, The Lancet.

[37]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[38]  Dennis C. Choi,et al.  Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness , 2003, Frontiers in Neuroendocrinology.

[39]  E. Widmaier,et al.  Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats. , 1992, Endocrinology.

[40]  Burton H Singer,et al.  Combinations of biomarkers predictive of later life mortality , 2006, Proceedings of the National Academy of Sciences.

[41]  Evangelia Charmandari,et al.  Endocrinology of the stress response. , 2005, Annual review of physiology.

[42]  D. Cota,et al.  Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. , 2007, Endocrinology.

[43]  J. Manzanares,et al.  Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat. , 1999, Life sciences.

[44]  H. Kaplan,et al.  THE PSYCHOSOMATIC CONCEPT OF OBESITY , 1957, The Journal of nervous and mental disease.

[45]  E. Widmaier,et al.  Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. , 1989, Endocrine reviews.

[46]  B. McEwen Protective and damaging effects of stress mediators. , 1998, The New England journal of medicine.

[47]  H. Selye A Syndrome produced by Diverse Nocuous Agents , 1936, Nature.

[48]  S. Lightman,et al.  The Neuroendocrinology of Stress: A Never Ending Story , 2008, Journal of neuroendocrinology.

[49]  Paul Hjemdahl Stress and the metabolic syndrome: an interesting but enigmatic association. , 2002, Circulation.

[50]  T. Wenger,et al.  Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. , 1997, Biochemical and biophysical research communications.

[51]  K. Brownell,et al.  Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior , 2001, Psychoneuroendocrinology.

[52]  M. Palkovits,et al.  Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. , 2001, Endocrine reviews.

[53]  U. Pagotto,et al.  The Hypothalamic‐Pituitary‐Adrenal Axis Activity in Obesity and the Metabolic Syndrome , 2006, Annals of the New York Academy of Sciences.

[54]  J. Manzanares,et al.  Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of Δ9-tetrahydrocannabinol in rats , 1999, Brain Research.

[55]  P. Björntorp,et al.  Mental distress, obesity and body fat distribution in middle-aged men. , 1996, Obesity research.

[56]  F. Holsboer,et al.  Stress and the brain: from adaptation to disease , 2005, Nature Reviews Neuroscience.

[57]  D. Porte,et al.  Leptin and insulin action in the central nervous system. , 2002, Nutrition reviews.

[58]  G. Chrousos,et al.  A healthy body in a healthy mind--and vice versa--the damaging power of "uncontrollable" stress. , 1998, The Journal of clinical endocrinology and metabolism.

[59]  E. Epel,et al.  Stress, eating and the reward system , 2007, Physiology & Behavior.

[60]  B. McEwen,et al.  Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[61]  H. Praag,et al.  Can stress cause depression? , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[62]  M. Herkenham,et al.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[63]  D. Bellar,et al.  Implications of the biology of weight regulation and obesity on the treatment of obesity , 2008, Journal of the American Academy of Nurse Practitioners.

[64]  H. Akil,et al.  Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  R. Mechoulam,et al.  Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. , 1994, Neuroendocrinology.

[66]  C. Tsigos,et al.  Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. , 2002, Journal of psychosomatic research.

[67]  D. Piomelli The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[68]  U. Pagotto,et al.  The Endocannabinoid System and Energy Metabolism , 2008, Journal of neuroendocrinology.

[69]  C. Shively,et al.  Social Stress, Visceral Obesity, and Coronary Artery Atherosclerosis in Female Primates , 2009, Obesity.

[70]  Oliver T. Wolf,et al.  Basal Hypothalamo-Pituitary-Adrenal Axis Activity and Corticotropin Feedback in Young and Older Men: Relationships to Magnetic Resonance Imaging-Derived Hippocampus and Cingulate Gyrus Volumes , 2002, Neuroendocrinology.

[71]  K. Dedovic,et al.  The Montreal Imaging Stress Task: using functional imaging to investigate the effects of perceiving and processing psychosocial stress in the human brain. , 2005, Journal of psychiatry & neuroscience : JPN.

[72]  S. Di,et al.  Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism , 2003, The Journal of Neuroscience.

[73]  L. Saksida,et al.  Visual perception and memory: a new view of medial temporal lobe function in primates and rodents. , 2007, Annual review of neuroscience.

[74]  M. Ingvar,et al.  Neuroendocrine, Cognitive and Structural Imaging Characteristics of Women on Longterm Sickleave with Job Stress–Induced Depression , 2006, Biological Psychiatry.

[75]  T. Freund,et al.  Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in mice , 2004, The European journal of neuroscience.

[76]  P. Govoni,et al.  Metabolic Consequences and Vulnerability to Diet-Induced Obesity in Male Mice under Chronic Social Stress , 2009, PloS one.

[77]  Shakti Sharma,et al.  Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. , 1997, Science.

[78]  P. Björntorp,et al.  Visceral obesity: a "civilization syndrome". , 1993, Obesity research.

[79]  S. Manuck,et al.  Endothelial dysfunction in response to psychosocial stress in monkeys. , 1991, Circulation research.

[80]  J. Herman,et al.  Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis , 1997, Trends in Neurosciences.

[81]  A. Aljada,et al.  The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm , 2002, Diabetologia.

[82]  B. Popkin,et al.  Environmental influences on food choice, physical activity and energy balance , 2005, Physiology & Behavior.